Report Categories
View AllRecent Articles
View All
AI Accelerates Drug Discovery for Brain Disorders Researchers Say
BP Sacks Chairman Albert Manifold Deepening Leadership Crisis at Energy Giant
ConocoPhillips Cash Flow Focus Remains Key Amid LNG Development Activity
Understanding Offer for Sale OFS A Key Mechanism for Shareholders to Exit
Marylands Innovation Ecosystem Could Reshape US Competitiveness in AI and Quantum Computing
ACTU Q1 2026 Earnings EPS Misses Estimates as Biotech Firm Continues RD Investment
FIGS Q1 2026 Earnings EPS Surges Past Estimates on Strong Profitability
CNTN Q4 2023 Earnings EPS Surprises Positively Despite Revenue Absence Stock Declines 65
ELTK Q1 2026 Earnings Loss Per Share of 042 Shares Rise 608 Despite No Revenue Disclosure
RDZN Q1 2026 Earnings Significant EPS Miss Amidst Transition
BCE Inc BCE Rallies Slightly Support and Resistance Levels in Focus
Gladstone Land LAND Shows Modest Uptick as It Approaches Key Resistance Level
KimberlyClark KMB Edges Higher as Defensive Appeal Supports Modest Gains
Live Ventures LIVE Slips 075 as Stock Hovers Near Key Support Level
ONGC Reports 46 Surge in Q4 Consolidated Net Profit to 10820 Crore
Supah Hot Fires Knockout of Ray J at Brand Risk 14 Highlights Celebrity Boxings Brand Strategy TradeOffs
Ohio Family Claims State Farm Roof Repair Offer May Violate State Insurance Laws
Traders Express Skepticism Over Irans Strait of Hormuz Reopening Timeline
External Links
Stratasys Acquires MarkForged in 425 Million AllCash Deal
TATT Q1 2026 Earnings Strong EPS Beat Signals Momentum in Aerospace Defense
Teekay Tankers Ltd Q1 2026 Earnings EPS Surpasses Estimates by 106 Amidst Robust Tanker Markets
VNDA Q1 2026 Earnings WiderThanExpected Loss Raises Concerns
COMPASS Pathways Plc Q1 2026 Earnings Narrower Loss Provides Hope Amid PreRevenue Stage
Tripcom Group TCOM Q4 2025 Earnings EPS Beats Estimates by 478 Amid Market Caution
IBM Q1 2026 Earnings Earnings Beat on Strong EPS Performance Stock Edges Higher
NTLA Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Stage Company Focuses on Pipeline Execution
GRRR Q4 2025 Earnings Significant EPS Miss Despite Positive Stock Reaction
EPR Properties Q1 2026 Earnings EPS Surges Past Expectations Amid Strong Experiential Demand